• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. BIOMET BC R 1X40 US; BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. BIOMET BC R 1X40 US; BONE CEMENT Back to Search Results
Catalog Number 110035368
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Synovitis (2094); Ambulation or Postural Difficulties (2544); Swelling/ Edema (4577)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported the patient has continuing pain, swelling, synovitis and difficulty ambulating six years, five months post implantation.Patient received topical lidocaine patches as treatment.An arthroscopic procedure was completed five years post implantation however symptoms persisted.No additional information provided by patient at this time.
 
Additional Manufacturer Narrative
(b)(4).D-10: (b)(6), 12mm diameter 100mm length straight stem extension combined length 145mm, lot# 63687921.(b)(6), nexgen distal femoral augment block, lot#: 63661850, (b)(6), nexgen all poly patella std cemented size 32mm dia 8.5m, m thick, lot#: 64107592, (b)(6), nexgen 14mm dia 100mm l offset stem extension, lot#: 63810697, (b)(6), nexgen left size e cemented option femoral component, lot#: 63939477, (b)(6), nexgen 12mm h size e, f w/locking screw green articular surface, lot#: 63564388, (b)(6), nexgen size 5 precoat stemmed a/p wedged tibial component, lot#: 63814253.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.No product was returned or pictures provided; a product evaluation could not be performed.A review of the device manufacturing records confirmed no abnormalities or deviations.Review of the complaint history identified additional similar complaints for the reported item and no additional similar complaints for the reported part and lot combination.Based on the available information, the reported event cannot be confirmed.A definitive root cause could not be determined if any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No further event information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMET BC R 1X40 US
Common Device Name
BONE CEMENT
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key21618260
Report Number3006946279-2025-00028
Device Sequence Number6827786
Product Code LOD
UDI-Device Identifier00887868214578
UDI-Public(01)00887868214578(17)221031(10)745DAI1807
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
K172408
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date10/31/2022
Device Catalogue Number110035368
Device Lot Number745DAI1807
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/19/2025
Supplement Date Received by Manufacturer06/18/2025
Initial Report FDA Received Date03/17/2025
Supplement Report FDA Received Date06/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/16/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11 NARRATIVE.
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexFemale
-
-